BlackRock, Inc. 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Athira Pharma, Inc. ATHA |
BLACKROCK INC BLK |
669,768 1.800% |
-1,693,453 (-71.66%) |
Filing |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Athira Pharma, Inc. ATHA |
BLACKROCK INC BLK |
2,363,221 6.200% |
-92,463 (-3.77%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
BLACKROCK INC BLK |
2,455,684 6.600% |
2,455,684 (New Position) |
Filing |